Deprescribing in Patients with Dementia: Less Is More - Frankly Speaking Ep 299

<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299</a></p> <p>Overview: Polypharmacy is a burden on patients with dementia. Adverse drug reactions, side effects, the cost, and inappropriate medications that may lead to falls and morbidity/mortality may be conferring more harm than benefit. Unfortunately, 44% of men and 57% of women >65 years take five or more nonprescription and/or prescription medications per day. Join us as we discuss methods for deprescribing polypharmacy in this patient population. </p> <p>Episode resource links:</p> <ul><li>Growdon, M. E., Gan, S., Yaffe, K., & Steinman, M. A. (2021). Polypharmacy among older adults with dementia compared with those without dementia in the United States. Journal of the American Geriatrics Society, 69(9), 2464–2475. PMID: 34101822 <a href='https://doi.org/10.1111/jgs.17291'>https://doi.org/10.1111/jgs.17291</a></li> <li>Narayan, S. W., & Nishtala, P. S. (2017). Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review. Drugs & aging, 34(10), 767–776. PMID: 28853000  <a href='https://doi.org/10.1007/s40266-017-0487-1'>https://doi.org/10.1007/s40266-017-0487-1</a></li> </ul> <p>Guest: Jill M. Terrien PhD, ANP-BC    Music Credit: Richard Onorato  </p>